SLC38A7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.522600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.591800E-01
Normal-vs-Stage2
4.877000E-01
Normal-vs-Stage3
1.605180E-01
Normal-vs-Stage4
5.078600E-01
Stage1-vs-Stage2
2.554200E-02
Stage1-vs-Stage3
3.828800E-01
Stage1-vs-Stage4
1.043150E-01
Stage2-vs-Stage3
1.759040E-01
Stage2-vs-Stage4
5.520400E-02
Stage3-vs-Stage4
4.574100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.213800E-01
Normal-vs-AfricanAmerican
6.265600E-01
Normal-vs-Asian
4.003800E-01
Caucasian-vs-AfricanAmerican
7.543200E-01
Caucasian-vs-Asian
5.879400E-01
AfricanAmerican-vs-Asian
5.891400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.046200E-01
Normal-vs-Female
3.907000E-01
Male-vs-Female
9.072200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.748800E-01
Normal-vs-Age(41-60Yrs)
6.194600E-01
Normal-vs-Age(61-80Yrs)
3.518400E-01
Normal-vs-Age(81-100Yrs)
7.972000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.340710E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.606800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.064800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.803700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.757800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.389200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.725210E-01
Normal-vs-Daily Drinker
1.133590E-01
Normal-vs-Weekly Drinker
7.212200E-01
Normal-vs-Occasional Drinker
5.689200E-01
Normal-vs-Social Drinker
8.123000E-01
Non Drinker-vs-Daily Drinker
4.445000E-01
Non Drinker-vs-Weekly Drinker
1.160790E-01
Non Drinker-vs-Occasional Drinker
1.975760E-01
Non Drinker-vs-Social Drinker
2.375700E-02
Daily Drinker-vs-Weekly Drinker
4.969900E-02
Daily Drinker-vs-Occasional Drinker
7.790300E-02
Daily Drinker-vs-Social Drinker
7.484600E-03
Weekly Drinker-vs-Occasional Drinker
7.430000E-01
Weekly Drinker-vs-Social Drinker
7.145000E-01
Occasional Drinker-vs-Social Drinker
4.387400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.614800E-01
Normal-vs-Grade 2
6.341600E-01
Normal-vs-Grade 3
1.348620E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.297400E-03
Grade 1-vs-Grade 3
6.162900E-04
Grade 1-vs-Grade 4
5.614800E-01
Grade 2-vs-Grade 3
5.149800E-02
Grade 2-vs-Grade 4
6.341600E-01
Grade 3-vs-Grade 4
1.348620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.516400E-01
Normal-vs-NonDiabetic
3.591200E-01
Diabetic-vs-NonDiabetic
6.190800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.259000E-01
Normal-vs-NoPancreatitis
3.715000E-01
Pancreatitis-vs-NoPancreatitis
9.138800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.417600E-01
Normal-vs-N1
5.224600E-01
N0-vs-N1
3.072400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.142200E-01
Normal-vs-TP53-NonMutant
3.365800E-01
TP53-Mutant-vs-TP53-NonMutant
3.392200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
